Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma

Jia Wang; Jie Zuo; Mao-De Wang; Wan-Fu Xie; Xiao-Bin Bai; Xu-Dong Ma

doi:10.1111/cns.13227

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma

CNS Neurosci Ther. 2020 Jul;26(7):777. doi: 10.1111/cns.13227. Epub 2019 Oct 2.

Authors

Jia Wang^{1

2}, Jie Zuo³, Mao-De Wang^{1

2}, Wan-Fu Xie¹, Xiao-Bin Bai¹, Xu-Dong Ma¹

Affiliations

¹ Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
² Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
³ The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Abstract

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, (https://doi.org/10.1111/cns.13227). The above article published online on 02 October 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions.

Publication types

Retracted Publication

Abstract

Publication types

Grants and funding